#AIDS Drug Assistance Program

A look at the supply chain that results in very high costs for HIV and hepatitis C medications.

Cost concerns have led many private insurers and public payers to impose restrictions on treatment.

Up to 30 percent of people living with HIV in the United States are also living with hep C.

A combined fiscal year 2010 spending bill including provisions to lift the 20-year-old ban on using federal funding for needle exchange...